T 1245/19 (Methods of synthesis and/or purification of diaminophenothiazinium compounds/WisTa Laboratories Ltd.) of 21.03.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T124519.20230321
- Date of decision
- 21 March 2023
- Case number
- T 1245/19
- Petition for review of
- -
- Application number
- 11173338.2
- IPC class
- C07D 279/18
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods of synthesis and/or purification of diaminophenothiazinium compounds
- Applicant name
- WisTa Laboratories Ltd.
- Opponent name
- Provepharm Life Solutions/Provepharm
Grünecker Patent- und Rechtsanwälte PartG mbB - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 76(1)European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 011Rules of procedure of the Boards of Appeal 2020 Art 012(2)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Admission of documents into the appeal proceedings
Admission of a decision of the BOA and arguments based thereon into the appeal proceedings
Main request - amendments allowable (Yes)
Main request - Sufficiency of disclsoure (Yes)
Lack of clarity does not lead to insufficiency of disclosure
Main request - Novelty (Yes)
Purity and impurity levels not inevitably reached
Remittal to the opposition division - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division for further prosecution.